-
URGN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
UroGen Pharma (URGN)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 125.99 mm | 125.99 mm | 125.99 mm | 125.99 mm | 125.99 mm | 125.99 mm |
Cash burn (monthly) | 2.09 mm | (no burn) | 7.86 mm | 8.32 mm | (no burn) | 5.16 mm |
Cash used (since last report) | 5.86 mm | n/a | 22.01 mm | 23.31 mm | n/a | 14.45 mm |
Cash remaining | 120.13 mm | n/a | 103.97 mm | 102.68 mm | n/a | 111.54 mm |
Runway (months of cash) | 57.5 | n/a | 13.2 | 12.3 | n/a | 21.6 |
13F holders | Current |
---|---|
Total holders | 85 |
Opened positions | 31 |
Closed positions | 10 |
Increased positions | 15 |
Reduced positions | 19 |
13F shares | Current |
---|---|
Total value | 111.43 bn |
Total shares | 13.18 mm |
Total puts | 29.00 k |
Total calls | 12.50 k |
Total put/call ratio | 2.3 |
Largest owners | Shares | Value |
---|---|---|
Menora Mivtachim | 2.53 mm | $26.18 bn |
BLK BlackRock | 1.10 mm | $11.36 bn |
Credit Suisse | 1.06 mm | $10.97 bn |
Harel Insurance Investments & Financial Services | 1.03 mm | $10.62 mm |
RTW Investments | 857.46 k | $8.87 bn |
Migdal Insurance & Financial | 698.30 k | $7.23 mm |
Opaleye Management | 570.00 k | $5.90 bn |
Clal Insurance Enterprises | 529.39 k | $5.48 mm |
Wildcat Capital Management | 495.61 k | $5.13 bn |
Stonepine Capital Management | 448.51 k | $4.64 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Oct 24 | Chris Degnan | Employee Stock Option Ordinary Shares | Grant | Acquire A | No | No | 13.11 | 74,142 | 972.00 k | 74,142 |
8 Oct 24 | Chris Degnan | RSU Ordinary Shares | Grant | Acquire A | No | No | 0 | 13,450 | 0.00 | 13,450 |
9 Sep 24 | Mark Schoenberg | Ordinary Shares | Sell | Dispose S | No | No | 13.08 | 859 | 11.24 k | 145,091 |
9 Sep 24 | Mark Schoenberg | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 1,666 | 0.00 | 145,950 |
9 Sep 24 | Mark Schoenberg | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 1,666 | 0.00 | 3,334 |
9 Sep 24 | Jason Drew Smith | Ordinary Shares | Sell | Dispose S | No | No | 13.08 | 1,521 | 19.89 k | 25,226 |
9 Sep 24 | Jason Drew Smith | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 3,333 | 0.00 | 26,747 |
9 Sep 24 | Jason Drew Smith | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 3,333 | 0.00 | 6,667 |
9 Sep 24 | Dong Kim | Ordinary Shares | Option exercise | Acquire M | No | No | 0 | 2,500 | 0.00 | 37,753 |
9 Sep 24 | Dong Kim | RSU Ordinary Shares | Option exercise | Dispose M | No | No | 0 | 2,500 | 0.00 | 5,000 |